Trial Profile
A retrospective study evaluating post-operative rivaroxaban in patients with total hip and total knee replacement surgery who received post-operative rivaroxaban
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Apr 2018
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Pulmonary embolism; Venous thrombosis
- Focus Therapeutic Use
- 02 Apr 2018 New trial record